| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |